Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Dr Reddy's rolls out generic cancer drug

PBR Staff Writer Published 28 July 2011

Dr Reddy's Laboratories has rolled out Gemcitabine for Injection (200 mg/vial and 1 g/vial) in the US market.

Dr Reddy's Gemcitabine for Injection is the generic version of a cancer medication, Gemzar.

Gemzar is indicated as a treatment for cancers of the pancreas, lung and breast as well as used in combination with carboplatin for the treatment of ovarian cancer.

The launching of the drug follows the US Food and Drug Administration approval for the abbreviated new drug application of Gemcitabine for injection.

Currently, Dr Reddy's Gemcitabine for Injection 200mg/vial and 1 g/vial strengths are available in single-use vials.